Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News aTyr Pharma Inc ATYR

Healthcare Biotechnology
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause... see more

Recent & Breaking News (NDAQ:ATYR)

Gold Plummets, Market Posts Biggest Drop of Year, and Dish Network Offers $25.5B for Sprint

PR Newswire April 16, 2013

Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Life Technologies Corporation (LIFE)

Business Wire April 15, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Life Technologies Corporation - LIFE

PR Newswire April 15, 2013

Life Technologies Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Thermo Fisher Scientific

Business Wire April 15, 2013

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Life Technologies Corp. Shareholders

Business Wire April 15, 2013

Rigrodsky & Long, P.A. Announces Investigation Of Life Technologies Corporation Buyout

Business Wire April 15, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Life Technologies Corporation in Connection with the Sale of the Company to Thermo Fisher Scientific, Inc.

Business Wire April 15, 2013

Block & Leviton LLP Investigates Life Technologies Corporation for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Thermo Fisher Scientific Inc.

PR Newswire April 15, 2013

Life Technologies Corporation Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Thermo Fisher Scientific

PR Newswire April 15, 2013

Key to Success, How to Profit: KORS, FDX, HMA and LIFE

Marketwired April 15, 2013

Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor

PR Newswire April 12, 2013

The Reason It Trades, What's Moving LIFE, MDLZ, VALE and MMM

Marketwired April 12, 2013

Pre-Market Analysis on Life Technologies, Quest Diagnostics, Brookdale Senior Living, Antares Pharma, and Optimer Pharma

PR Newswire April 12, 2013

Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data

PR Newswire April 11, 2013

Law Office of Brodsky & Smith, LLC Announces Investigation of Life Technologies Corporation

PR Newswire April 10, 2013

Life Technologies Launches Oncomine® Bioinformatics Solutions for Cancer Researchers

PR Newswire April 4, 2013

Life Technologies to Invest $18 Million in Facility Expansion and Current Good Manufacturing Practice Compliance Plan

PR Newswire March 28, 2013

Life Technologies Announces SFDA Clearance for its 3500xL Dx Genetic Analyzer in China and the Launch of 10 Assays from its Joint Venture with Daan Gene

PR Newswire March 27, 2013

BioMed Realty To Lease 204,900 Square Feet To Life Technologies At The Science Center at Oyster Point In South San Francisco

PR Newswire March 20, 2013

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 Fast DX Real-Time PCR Instruments

Marketwired March 18, 2013